Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2013
09/03/2013US8524775 Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents (PSOA)
09/03/2013US8524774 Topical two step polytherapy for treatment of psoriasis and other skin disorders
09/03/2013US8524773 Utilization of dialkylfumarates
09/03/2013US8524772 Controlled release of N-acetylcysteine (NAC) for reduction of systemic and/or vascular inflammation
09/03/2013US8524771 Wound and skin care compositions
09/03/2013US8524769 Oxidation, acetylation, solvent extraction
09/03/2013US8524768 Antioxidants for preventing and treating diseases caused by oxidative stress
09/03/2013US8524767 Modulators of ATP binding cassette transporters
09/03/2013US8524766 Modulators of dopamine neurotransmission
09/03/2013US8524765 Compounds that modulate intracellular calcium
09/03/2013US8524764 Inhibitors of Flaviviridae viruses
09/03/2013US8524763 Inhibitors of store operated calcium release
09/03/2013US8524762 Thioxanthone-based autophagy inhibitor therapies to treat cancer
09/03/2013US8524761 Phenoxy-pyrrolidine derivative and its use and compositions
09/03/2013US8524760 HCV protease inhibitors and uses thereof
09/03/2013US8524759 Phenylbutazone carrier formulation showing increased bioactivity in animals
09/03/2013US8524758 Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia
09/03/2013US8524757 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
09/03/2013US8524756 Compounds for inflammation and immune-related uses
09/03/2013US8524755 Specific diarylhydantoin and diarylthiohydantoin compounds
09/03/2013US8524754 Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio) acetate, and uses thereof
09/03/2013US8524753 Compounds that are useful for improving pharmacokinetics
09/03/2013US8524752 Thiazolidin-4-one derivatives
09/03/2013US8524751 4-oxadiazol-2-YL-indazoles as inhibitors of P13 kinases
09/03/2013US8524750 (Pyrazol-3-yl)-1,3,4-thiadiazol-2-amine and (pyrazol-3-yl)-1,3,4-thiazol-2-amine compounds
09/03/2013US8524749 Administering a dosage form of 6-20 mg of tizanidine; plasma drug concentration substantially ascends over a period of 8 hours following administration
09/03/2013US8524748 Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors
09/03/2013US8524747 Pharmaceutical compositions
09/03/2013US8524746 Dosage regimen for COMT inhibitors
09/03/2013US8524745 Benzisothiazol-3(1H)-one-5-sulfonyl derivatives as chemokine receptor modulators
09/03/2013US8524744 Arylamine ketones, their preparation methods, the pharmaceutical composition containing them and their use
09/03/2013US8524742 Use of 5H-thioeno(3,4-c)pyrrole-4,6-dione derivatives as tumor necrosis factor inhibitor
09/03/2013US8524741 Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing cognitive and physical performance
09/03/2013US8524740 Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives
09/03/2013US8524739 Quinoline derivatives and uses thereof
09/03/2013US8524738 Quinolinones and quinoxalinones as antibacterial composition
09/03/2013US8524737 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
09/03/2013US8524735 Aerosolized fluoroquinolones and uses thereof
09/03/2013US8524734 Aerosolized fluoroquinolones and uses thereof
09/03/2013US8524733 Benzoquinoline inhibitors of vesicular monoamine transporter 2
09/03/2013US8524732 Substituted tetrahydroquinolines
09/03/2013US8524731 Use of opioid antagonists to attenuate endothelial cell proliferation and migration
09/03/2013US8524730 Spirochromanone carboxylic acids
09/03/2013US8524729 Cinnamoyl derivatives and use thereof
09/03/2013US8524728 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
09/03/2013US8524727 Pyrimidine compound
09/03/2013US8524725 Methods of using diaminopyrimidine as P2X3 and P2X⅔ receptor modulators for treatment of respiratory and gastrointestinal diseases
09/03/2013US8524724 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
09/03/2013US8524723 Polymorphs of methyl 3-(E)-2-{2-[6-(2-cyanophenoxy) pyrimidin-4-yloxy] phenyl}-3-methoxyacrylate
09/03/2013US8524722 Substituted tricyclic compounds and methods of use thereof
09/03/2013US8524721 Platelet ADP receptor inhibitors
09/03/2013US8524720 Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors
09/03/2013US8524719 Therapeutic compounds for blocking DNA synthesis of pox viruses
09/03/2013US8524718 Heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
09/03/2013US8524717 Oxidase inhibitors and their use
09/03/2013US8524716 Macrocyclic indoles as hepatitis C virus inhibitors
09/03/2013US8524715 Phenoxyacetic acid derivatives useful for treating respiratory diseases
09/03/2013US8524714 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
09/03/2013US8524713 Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands
09/03/2013US8524712 Triazinone and diazinone derivatives useful as HSP90 inhibitors
09/03/2013US8524711 Amino-derivatives as novel inhibitors of histone deacetylase
09/03/2013US8524710 Pyrrolidine derivatives
09/03/2013US8524709 Kinase inhibitor compounds
09/03/2013US8524708 Oxadiazoanthracene compounds for the treatment of diabetes
09/03/2013US8524707 Bicyclic pyrazoles as protein kinase inhibitors
09/03/2013US8524706 1,4-diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof
09/03/2013US8524705 2-oxo-2-(2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl)-acetamide derivatives and related compounds as antifungal agents
09/03/2013US8524704 Azepinoindole derivatives as pharmaceutical agents
09/03/2013US8524703 Bridgehead amine ring-fused indoles and indolines
09/03/2013US8524702 Substituted benzoazepines as toll-like receptor modulators
09/03/2013US8524701 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
09/03/2013US8524700 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
09/03/2013US8524699 Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors
09/03/2013US8524698 Methods of treating hypertriglyceridemia
09/03/2013US8524697 C20-C21 substituted glucocorticoid receptor agonists
09/03/2013US8524696 Water-soluble compositions of bioactive lipophilic compounds
09/03/2013US8524695 Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
09/03/2013US8524694 Aminoalkylsterol compounds with antitumoral and neuroprotective activity
09/03/2013US8524693 Process for obtaining 17-spirolactones in steroids
09/03/2013US8524692 Ocular compositions containing dioleoylphosphatidylglycerol and uses thereof
09/03/2013US8524691 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
09/03/2013US8524690 DNA polymerase inhibitors composition and methods
09/03/2013US8524689 Antibacterial aminoglycoside analogs
09/03/2013US8524688 Use of sulfated glycosaminoglycans for establishing effective labor in women
09/03/2013US8524687 Ophthalmic pharmaceutical compositions based on amino acids and sodium hyaluronate
09/03/2013US8524686 Composition for prevention or treatment of eye diseases
09/03/2013US8524685 Anti-angiogenic therapeutics efficacy enhanced by nanoformulation
09/03/2013US8524681 siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof
09/03/2013US8524675 Antibacterial aminoglycoside analogs
09/03/2013US8524673 Pharmaceutical formulation
09/03/2013US8524665 Use of secretin in treatments of disorders associated with the amygdala
09/03/2013US8524660 Polyalkylene polymer compounds and uses thereof
09/03/2013US8524654 Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation
09/03/2013US8524637 Composition for controlling pests and method for controlling pests
09/03/2013US8524636 Synergistic combination of a glyphosate compound and IPBC
09/03/2013US8524460 PSCA: prostate stem cell antigen and uses thereof
09/03/2013US8524281 Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
09/03/2013US8524279 Atomizing nozzles include a liquid nozzle adapted to disperse a supply of liquid and a gas nozzle adapted to disperse a supply of gas; spray drying at a commercial plant scale.
09/03/2013US8524274 Liposomal composition comprising an active ingredient for relaxing smooth muscle, the production of this composition and the therapeutic use thereof
09/03/2013US8524273 Transdermal absorption preparation